期刊文献+

氟伐他汀对产科抗磷脂综合征患者血清活化内皮细胞的影响 被引量:1

Fluvastatin inhibits endothelial cell activation induced by the serum of patients with obstetric antiphospholipid syndrome
下载PDF
导出
摘要 目的:研究氟伐他汀对产科抗磷脂综合征(APS)患者血清活化内皮细胞的影响。方法:分别用APS患者血清、健康对照血清及培养基处理人脐静脉内皮细胞(HU-VEC),其中APS血清处理组预先加入不同浓度的氟伐他汀(0、2.5、5和10μmol/L)干预,用逆转录定量聚合酶链反应(RT-PCR)检测脐静脉内皮细胞上细胞间黏附分子-1(ICAM-1)mRNA表达,用流式细胞仪检测其蛋白的表达。结果:与对照组相比,APS患者血清可诱导ICAM-1 mRNA和蛋白表达增加,而氟伐他汀干预对ICAM-1 mRNA和蛋白表达有不同程度的抑制,且呈浓度依赖性(P<0.05)。结论:氟伐他汀可减少脐静脉内皮细胞黏附分子表达,影响抗磷脂综合征患者血管内皮活化。提示他汀类药物可为治疗APS提供新的选择。 Objective:To investigate whether fluvastatin interferes with endothelial cell (EC) activation induced by the serum of patients with obstetric antiphospholipid syndrome. Methods:Human umbilical vein endothelial cells were treated with serum from APS patients, normal controls, medium respectively. Cells were pretreated with fluvastatin (0,2.5,5 and 10μmol/L) before treated with APS serum. ICAM-1 mRNA was measured by reverse transcriptase-polymerase chain reaction and its antigen by flow cytometry. Results: Incubation of EC with APS serum led to a higher ICAM-1 expression compared with incubation with control serum. Fluvastatin treatment of the cells significantly reduced the ICAM-1 response to APS serum, and this effect was dose dependent (P 〈 0.05 ). Conclusions: Fluvastatin exerts a protective effect towards APS serum at the EC level by decreasing leukocyte adhesion molecule expression on endothelial cells. This data provide a rationale for using statins as a therapeutic tool in treatment of APS.
出处 《现代妇产科进展》 CSCD 北大核心 2008年第12期890-893,共4页 Progress in Obstetrics and Gynecology
关键词 抗磷脂综合征 内皮细胞 氟伐他汀 细胞间黏附分子-1 Antiphospholipid syndrome Endothelial cells Fluvastatin Intercellular adhesion molecule-1
  • 相关文献

参考文献12

  • 1林其德,肖云山.抗磷脂综合征与病理妊娠[J].中国实用妇科与产科杂志,2004,20(5):264-266. 被引量:42
  • 2Chen PP, Lin YC, Wu KC, et al. Activation of endothelial cells by antiphospholopid antibodies: a possible mechanism triggering thrombosis in patients with antiphospholopid syndrome[ J ]. Kaohsiung J Med Sci, 2006,10 : 484- 490
  • 3Pierangeli SS, Harris EN. Probing antiphospholipid-mediated thrombosis:the interplay between anticardiolipin antibodies and endothelial cells[J]. Lupus,2003,7:539-545
  • 4Raschi E, Testoni C, Borghi MO, et al. Endothelium activation in the anti-phospholipid syndrome [ J ]. Biomed Pharmacother, 2003 : 282-286
  • 5Meroni PL, Raschi E, Testoni C, et al. Endothelial cells activation by antiphospholipid antibodies [ J ]. Clin Immunol,200d ,2 : 169-174
  • 6Meroni PL, Raschi E, Testoni C, et al. Innate immunity in the antiphospholipid syndrome:role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies[ J]. Autoimmun Rev,2004,9:510-515
  • 7Ferrara DE, Liu X, Espinola RG, et al. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model [ J]. Arthritis Rheum,2003,48:3272-3279
  • 8Meroni PL, Raschi E, Testoni C, et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies:effect on the proadhesive and proinflammatory phenotype [ J ]. Arthritis Rheum,2001,44 : 2870-2878
  • 9Meroni PL, Raschi E, Testoni C. Endothelimn as a target for anti-pbospholipid antibodies and for therapeutical intervention [ J ]. Autoimmun Rev,2002,1:55-60
  • 10Dunoyer Geindre S, Dimitrova Y, Fish R J, et al. Fluvastatin increases the expression of adhesion molecules, monocyte chemoattractant protein-1 and tissue factor in HUVEC stimulated by patient IgG fractions containing antiphospholipid antibodies [ J ]. Thromb Haemost, 2005, 2:339-345

二级参考文献9

  • 1林其德,周涵春.原因不明性习惯性流产的免疫学诊断与治疗[J].中华妇产科杂志,1993,28(3):143-146. 被引量:41
  • 2林其德,周涵春.复发性流产与自身抗体关系的探讨[J].中华妇产科杂志,1993,28(11):674-677. 被引量:49
  • 3Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol, 2003,101 (6): 1333-1344
  • 4Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol,2001,96(1) :37-50
  • 5Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment. J Reprod Immunol, 2002,57(1 ): 185-202
  • 6Voss A, Jacobsen S, Heegaard NH. Association of beta2-glycoprotein IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus, 2001,10(8): 533-538
  • 7Lockshin MD,Branch DW,Piette JC,et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999,42(50): 1309-1331
  • 8Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun, 2000,15 ( 1 ): 163-172
  • 9谈蕴珏,林其德,赵爱民.复发性流产与抗心磷脂抗体关系探讨[J].中国免疫学杂志,1999,15(12):545-546. 被引量:13

共引文献41

同被引文献21

  • 1Holmgren C, Aagaard-Tillery KM, Rice J, et al. Associationbetween antiphospholipid antibodies and recurrent early miscarriage- Does a syndrome actually exist?[J]. J Reprod Immunol, 2006, 71(2) : 154.
  • 2Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on all update of the classification criteria for definite antiphospholipid syndrome (APS) [J]. Thromb Haemost, 2006, 4:295-306.
  • 3Rand JH, Wu XX, Quinn AS, et al. The annexin AS- mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis [J]. Lupus, 2010, 19(4) : 460-469.
  • 4Rand JH, Wu XX, Quinn AS, et al. Human monoclonal antiphospholipid antibodies disrupt the annexina5 anticoagulant crystal shield on phospholipids bilayers: evidence from atomic force microscopy and functional assay [J]. Am J Pathol, 2003, 163(3):1193-1200.
  • 5Shamonki JM, Salmon JE, Hyjek E, et al. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies [ J ]. Obstet Gynecol, 2007, 196(2) : 167. el-e5.
  • 6Meroni PL, Tedesco F, Locati M, et al. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view[J]. Lupus, 2010, 19(4):453-456.
  • 7Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss[J]. Exp Med, 2002, 195(2) :211-220.
  • 8Girardi G, Berman J, Redecha P, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome[J]. J Clin Invest, 2003, 112 (11) : 1644-1654.
  • 9Berman J, Girardi G, Salmon JE, et al. TNF-a is a critical effector and a target for therapy in antiphospholipid antibody- induced pregnancy loss [J]. J Immunol, 2005, 174 (1) : 485-490.
  • 10Thurman JM, Kraus DM, Girardi G, et al. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice[J]. Mol Immunol, 2005, 42(1):87-97.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部